Bornancin F - Search Results

1

The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.

Pastukhov O, Schwalm S, Zangemeister-Wittke U, Fabbro D, Bornancin F, Japtok L, Kleuser B, Pfeilschifter J, Huwiler A. Pastukhov O, et al. Among authors: bornancin f. Br J Pharmacol. 2014 Dec;171(24):5829-44. doi: 10.1111/bph.12886. Br J Pharmacol. 2014. PMID: 25134723 Free PMC article.

2

Ceramide kinase: the first decade.

Bornancin F. Bornancin F. Cell Signal. 2011 Jun;23(6):999-1008. doi: 10.1016/j.cellsig.2010.11.012. Epub 2010 Nov 25. Cell Signal. 2011. PMID: 21111813 Review.

3

Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor.

Graf C, Klumpp M, Habig M, Rovina P, Billich A, Baumruker T, Oberhauser B, Bornancin F. Graf C, et al. Among authors: bornancin f. Mol Pharmacol. 2008 Oct;74(4):925-32. doi: 10.1124/mol.108.048652. Epub 2008 Jul 8. Mol Pharmacol. 2008. PMID: 18612076

4

A secondary assay for ceramide kinase inhibitors based on cell growth inhibition by short-chain ceramides.

Graf C, Rovina P, Bornancin F. Graf C, et al. Among authors: bornancin f. Anal Biochem. 2009 Jan 1;384(1):166-9. doi: 10.1016/j.ab.2008.09.008. Epub 2008 Sep 14. Anal Biochem. 2009. PMID: 18831956

5

Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro.

Niwa S, Graf C, Bornancin F. Niwa S, et al. Among authors: bornancin f. Microvasc Res. 2009 May;77(3):389-93. doi: 10.1016/j.mvr.2009.01.006. Epub 2009 Feb 6. Microvasc Res. 2009. PMID: 19323974

6

Enhanced ceramide-induced apoptosis in ceramide kinase overexpressing cells.

Graf C, Rovina P, Tauzin L, Schanzer A, Bornancin F. Graf C, et al. Among authors: bornancin f. Biochem Biophys Res Commun. 2007 Mar 2;354(1):309-14. doi: 10.1016/j.bbrc.2006.12.208. Epub 2007 Jan 8. Biochem Biophys Res Commun. 2007. PMID: 17222802

7

Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.

Bornancin F, Renner F, Touil R, Sic H, Kolb Y, Touil-Allaoui I, Rush JS, Smith PA, Bigaud M, Junker-Walker U, Burkhart C, Dawson J, Niwa S, Katopodis A, Nuesslein-Hildesheim B, Weckbecker G, Zenke G, Kinzel B, Traggiai E, Brenner D, Brüstle A, St Paul M, Zamurovic N, McCoy KD, Rolink A, Régnier CH, Mak TW, Ohashi PS, Patel DD, Calzascia T. Bornancin F, et al. J Immunol. 2015 Apr 15;194(8):3723-34. doi: 10.4049/jimmunol.1402254. Epub 2015 Mar 11. J Immunol. 2015. PMID: 25762782

8

MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer.

Lee JL, Ekambaram P, Carleton NM, Hu D, Klei LR, Cai Z, Myers MI, Hubel NE, Covic L, Agnihotri S, Krappmann D, Bornancin F, Lee AV, Oesterreich S, McAllister-Lucas LM, Lucas PC. Lee JL, et al. Among authors: bornancin f. Mol Cancer Res. 2022 Mar 1;20(3):373-386. doi: 10.1158/1541-7786.MCR-21-0208. Mol Cancer Res. 2022. PMID: 34753803 Free PMC article.

9

Characterization of a ceramide kinase-like protein.

Bornancin F, Mechtcheriakova D, Stora S, Graf C, Wlachos A, Dévay P, Urtz N, Baumruker T, Billich A. Bornancin F, et al. Biochim Biophys Acta. 2005 Feb 21;1687(1-3):31-43. doi: 10.1016/j.bbalip.2004.11.012. Biochim Biophys Acta. 2005. PMID: 15708351

10

Transcriptional repression of ceramide kinase in LPS-challenged macrophages.

Rovina P, Jaritz M, Bornancin F. Rovina P, et al. Among authors: bornancin f. Biochem Biophys Res Commun. 2010 Oct 8;401(1):164-7. doi: 10.1016/j.bbrc.2010.09.041. Epub 2010 Sep 16. Biochem Biophys Res Commun. 2010. PMID: 20849823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page